The Early Bird Discount ends this Friday, July 19!

The inaugural Macrophage-directed Therapies Summit is the only platform dedicated to helping leaders from pharma, biotech and academic institutes to successfully achieve clinical proof of concept when translating macrophage therapies into the clinic whilst ensuring safety, control and effective combination therapies

Join your macrophage community and discuss strategies to characterize macrophage biology to understand their role in tumor progression and improve targeting precision to prevent off-tumor toxicities.

Network and learn from the trailblazers of macrophage therapeutic development including Carisma Therapeutics, Merck and ALX Oncology across 3 days packed with dedicated, interactive formats exploring the drug development of CD47 checkpoint blockades, engineered macrophages as well as macrophage repolarization and depletion.

Download the event guide for the full agenda and speaker faculty.

This meeting is increasingly becoming the venue for significant breaking news in the field"

Past Attendee from the Cell & Viral Immunotherapy Series, Tmunity Therapeutics

 

“This summit is an ideal size and attracts the key players in the field. Good opportunity for networking and getting the relevant updates about progress in the space."

Past Attendee from the Cell & Viral Immunotherapy Series, GSK

Proud To Partner With

Lead Partner